NCT00793559

Terlipressin Administration in Septic Shock Refractory to Catecholamines

Terlipressin Administration in Septic Shock Refractory to Catecholamines Bolus vs. Continuous Drip-Phase II

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Assaf-Harofeh Medical Center · Other Government
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

terlipressin is given to refractory septic shock patients who do not respond to noradrenalin in Israel and Europe. It is given by bolus injection. we attempt to investigate weather it is better to give it by continuous drip and avoid abrupt changes in BP and heart function

Conditions

• Septic Shock

Interventions

Type	Name	Description
DRUG	terlipressin	1 mg of terlipressin one time only
DRUG	terlipressin	1 mg of terlipressin in 50 cc of NS given at a drip of a total of 6 h

Timeline

• Start date: 2008-11-01
• Primary completion: 2009-07-01
• Completion: 2009-07-01
• First posted: 2008-11-19
• Last updated: 2008-11-19

Locations

1 site across 1 country: Israel